BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Sound Pharmaceuticals, Inc. 

4010 Stone Way, N Suite 120

Seattle  Washington  98103  U.S.A.
Phone: 206-634-2559 Fax: 206-634-2342


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Sound Pharmaceuticals, Inc. Submits Positive Phase 2 Clinical Trial Data On SPI-1005 For The Prevention And Treatment Of Sensorineural Hearing Loss 2/18/2014 7:09:50 AM
Sound Pharmaceuticals, Inc. Successfully Completes Its First Phase 2 Clinical Trial With SPI-1005 Involving iPod® or Noise Induced Hearing Loss 11/5/2013 9:43:00 AM
Sound Pharmaceuticals, Inc. Release: University of Florida Begins iPod® Trial With SPI-1005 to Prevent Hearing Loss 12/6/2012 10:18:58 AM
Nobel Prize Winner Bruce Beutler Joins Sound Pharmaceuticals, Inc. 11/29/2012 11:39:18 AM
Sound Pharmaceuticals, Inc. Announces a New SPI-1005 Clinical Trial Involving Personal Music Players 6/6/2011 10:27:24 AM
University of California, Los Angeles (UCLA) and Sound Pharmaceuticals, Inc. Identify a Key Hearing Regeneration Protein in the Human Inner Ear 2/25/2011 7:10:26 AM
Sound Pharmaceuticals, Inc. Receives an Office of Naval Research Award for Its Hearing Loss Research and Development 8/20/2009 7:46:45 AM
FDA Allows Phase 2 Study for Sound Pharmaceuticals, Inc.'s Novel Drug to Prevent Chemotherapy Induced Hearing Loss 8/8/2008 6:08:55 AM
Sound Pharmaceuticals, Inc. Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 7/24/2008 6:47:10 AM
Sound Pharmaceuticals, Inc. Receives Additional DoD Funding for Its Hearing Regeneration Product 7/21/2008 7:23:35 AM
12